BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 19, 2009
View Archived Issues
Cytos reports patient allergy diary results from phase II CYT003-QbG10 study
Read More
Intra-Cellular reports top-line phase II ITI-007 results in insomnia
Read More
MediciNova reports phase II MN-221 data from emergency department study
Read More
Fornix reports 1-year follow-up results from clinical study of Oralgen in hay fever
Read More
FDA approves Alcon's IND application for NovaBay's NVC-422 for eye infections
Read More
Modigene reports results from pilot toxicity study of hGH-CTP in primates
Read More
FDA accepts for review ISTA's NDA for Bepreve for allergic conjunctivitis
Read More
Acceleron selects ACE-536 as new development candidate for anemia
Read More
Mologen reports successful results from ongoing phase I clinical trial of MGN-1703 for cancer
Read More
SIGA receives favorable guidance from EMEA regarding marketing authorization for ST-246
Read More
Benefit seen with multi-herbal product Yi-Gan San in vascular dementia patients
Read More
Phase II studies assess poly-ICLC in glioblastoma, anaplastic glioma
Read More
WHIMS-MRI Study evaluates effects of hormone therapy on brain volume, lesions
Read More
HDL nanoparticles synthesized
Read More
Copernicus and the University of Kentucky to collaborate on DNA therapy for PD
Read More
The Medicines Company to acquire Targanta Therapeutics
Read More
Analgesic calcium channel alpha2-delta subreceptor ligands claimed by Kyowa Hakko Kirin
Read More
iBioPharma reports results from preclinical animal studies of H5N1 subunit vaccine
Read More
Novel mgluR5 positive allosteric modulators developed at GSK for schizophrenia
Read More
DiaMedica cleared to commence second phase II DM-71 trial in type 2 diabetes
Read More
Scientists at Janssen describe new analgesic FAAH inhibitors in recent patent
Read More
Genentech to initiate pivitol phase II hedgehog pathway inhibitor trial in BCC
Read More
Peptimmune grants Novartis exclusive option to license PI-2301 for MS
Read More
Yakult launches anticancer drug Elplat 50 mg in Japan
Read More
Novel K(ATP) channel blockers claimed for cardiovascular disorders by sanofi-aventis
Read More
Novel protein kinase inhibitors with anticancer properties disclosed by Takeda
Read More